D2 Fund is an early-stage venture capital firm based in London that backs capital-efficient B2B software businesses across the UK and Europe. The fund invests up to £2M in founders solving technical challenges, with a focus on durable, mission-critical products.
33% of their portfolio is in SaaS. Their most common stage is seed (50% of deals). Average disclosed round size is $6.0M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Seed
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Asterix Health | Pre-Seed | — | Jan 2026 |
 Curvestone | Seed | $4M | Dec 2025 |
| MMenlo79 | Unknown | — | Jan 2025 |
 Xapien | Series A | $10M | Jul 2024 |
 Moxso | Seed | $5.5M | — |
| Xapien | Seed | $4.5M | — |
Top Co-Investors
Founders Factory2 shared
YFM Equity Partners2 shared
Boost Capital Partners1 shared
Portfolio Ventures1 shared
MTech Capital1 shared
Entrepreneurs First1 shared
Triple Point Ventures1 shared
#ANGELS1 shared
Ugly Duckling Ventures1 shared
SEED Capital1 shared
Last updated: 19 September 2026